PGP and osteosarcoma: While high P-gp expression has been reported to correlate with poor osteosarcoma prognosis, its clinical utility as a predictive biomarker is far from established.[7–9] Studies yield conflicting results, with some demonstrating a positive association between P-gp levels and adverse outcomes, while others fail to find any significant correlation.[7–9]